Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (5): 1071-1074    DOI: 10.31083/j.ceog4805172
Original Research Previous articles | Next articles
Can serum biochemical markers be used to establish a relationship between idiopathic polyhydramnios and antenatal aneuploidy?
Ozgur Sahin1, H. Egemen Tolunay2, Tufan Arslanca3, *(), S. Banu Arslanca2
1Department of Obstetrics and Gynecology, Canakkale State Hospital, 17010 Canakkale, Turkey
2Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity and Women's Health Teaching and Research Hospital, 06070 Ankara, Turkey
3Department of Obstetrics and Gynecology, Ufuk University, 06510 Ankara, Turkey
Download:  PDF(99KB)  ( 54 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: Polyhydramnios is a common cause of adverse pregnancy outcomes. The prediction of polyhydramnios in early pregnancy may lead to improved treatments and will diminish these adverse outcomes. Objective: This study aims to investigate the role of biochemical markers in antenatal screening tests to predict idiopathic polyhydramnios. Methods: Patient records were retrospectively evaluated in this case-control group study. Pregnant women (160 in total) were included in the study (this included 47 pregnant women diagnosed with idiopathic polyhydramnios and 113 healthy pregnant women as a control group). Results: Alpha-fetoprotein, unconjugated estriol, and total beta-human chorionic gonadotropin values were similar in both groups (p = 0.296, p = 0.573, p = 0.284). There was no significant difference between the group diagnosed with idiopathic polyhydramnios and the control group when the first-trimester screening test parameter, pregnancy-associated plasma protein-A, was examined (p = 0.102). Conclusion: Biochemical markers examined in prenatal screening tests in the first and second trimesters were insufficient to predict idiopathic Polyhydramnios. The reasons for this are that our study was retrospective, and the patient population was low. We believe that a prospective study with a larger population of patients should be conducted for more meaningful results.
Key words:  Antenatal screening      Biochemical markers      Polyhydramnios     
Submitted:  11 December 2020      Revised:  28 January 2021      Accepted:  14 February 2021      Published:  15 October 2021     
*Corresponding Author(s):  Tufan Arslanca     E-mail:  drtufanarslanca@hotmail.com

Cite this article: 

Ozgur Sahin, H. Egemen Tolunay, Tufan Arslanca, S. Banu Arslanca. Can serum biochemical markers be used to establish a relationship between idiopathic polyhydramnios and antenatal aneuploidy?. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1071-1074.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog4805172     OR     https://ceog.imrpress.com/EN/Y2021/V48/I5/1071

[1] Oana Sorina Tica, Andrei Adrian Tica, Doriana Cojocaru, Irina Tica, Victor Cojocaru, Vlad Iustin Tica. Single umbilical artery: a continuous dilemma and challenge in obstetric management[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1200-1205.
[2] C. Baykal, S. Kaya, M.K. Takal, Ü. Yakupoğlu. Successful management of a high-risk pregnancy with polyhydramnios, IUGR and recurrent pregnancy loss in a chronic renal failure patient: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2011, 38(1): 99-101.
[3] B. Dane, C. Dane, F. Aksoy, A. Cetin, M. Yayla. Arthrogryposis multiplex congenita: Analysis of twelve cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2009, 36(4): 259-262.
[4] L. M. M. Nardozza, G. R. Lobo, A. F. Moron, L. Camano, E. Araujo, Jr., H. A. Guimarães Filho. Anti-Lewis alloimmunization: report of seven cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2008, 35(4): 237-239.
[5] N. C. Nogueira De Souza, C. A. O. Botelho, M. R. Honer. Retrospective study of a pioneer antenatal screening program with 8,477 pregnant women in Brazil[J]. Clinical and Experimental Obstetrics & Gynecology, 2004, 31(3): 217-220.
[6] J. Krawczyk, S. Sajdak, J. Piatek. Biochemical markers of bone turnover in girls with secondary amenorrhoea[J]. Clinical and Experimental Obstetrics & Gynecology, 2002, 29(3): 189-190.
[7] A. Kuruvilla, G. Busby, S. Ramsewak. Use of continuous fluid drainage for severe polyhydramnios due to twin to twin transfusion syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2001, 28(2): 123-125.
[8] S. Sajdak, J. Krawczyk, J. Piątek, Z. Kopczyński. The applicability of biochemical markers of bone metabolism for predicting the risk of bone fractures and for the assessment of bone tissue resorption in the course of osteoporosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2000, 27(2): 118-120.
[9] H. Seeger, A. O. Mueck, A. T. Teichmann, T. H. Lippert. Effect of sequential estrogen/progestin treatment on biochemical vasoactive markers in postmenopausal women comparing oral and transdermal application[J]. Clinical and Experimental Obstetrics & Gynecology, 2000, 27(1): 17-20.
No Suggested Reading articles found!